July 2025 Br J Cardiol 2025;32(3) doi:10.5837/bjc.2025.033 Online First
Sasha T Gold, Muhammad H Riaz, Fraser C Goldie, Adrian J B Brady
Introduction Low-density lipoprotein-cholesterol (LDL-C) is accepted as a causal risk factor for development of atherosclerotic cardiovascular disease (CVD) and acute coronary syndromes (ACS).1 European Society of Cardiology (ESC) guidelines have been extensive in setting up lipid targets for primary and secondary prevention of CVD.2 The 2021 ESC guidelines carry forward the 2019 ESC dyslipidaemia targets to introduce a therapeutic regimen that achieves a ≥50% LDL-C reduction from baseline and a LDL-C goal of <1.4 mmol/L (<55 mg/dL) (very-high-risk group) or <1.8 mmol/L (high-risk group).2 The updated National Institute for Health
June 2025 Br J Cardiol 2025;32(2) doi:10.5837/bjc.2025.027 Online First
Chukwuemeka Lekwa, Jomith Jose, Saad Ahmad, Sunita Avinash
Introduction Acute myocardial infarction (AMI) in young patients with systemic inflammatory diseases, such as ulcerative colitis and diabetes mellitus, presents a unique clinical challenge that deviates from traditional cardiovascular risk models. This case aims to highlight the complexities of managing AMI in the presence of systemic inflammation and metabolic disorders, emphasising the need for comprehensive care strategies and a multi-specialty approach for effective management in such cases. The report is relevant to current practice, as it stresses the importance of integrated and interdisciplinary care in managing cardiovascular risk in
June 2018 Br J Cardiol 2018;25:73–6 doi:10.5837/bjc.2018.016
Miles Fisher, Emma Johns, Gerry McKay
(more…)
March 2018 doi:10.5837/bjc.2018.007
Emma Johns, Gerry McKay, Miles Fisher
(more…)
November 2017 Br J Cardiol 2017;24:152–5 doi:10.5837/bjc.2017.030
Emma Johns, Gerry McKay, Miles Fisher
(more…)
July 2017 Br J Cardiol 2017;24:113–16 doi:http://doi.org/10.5837/bjc.2017.018 Online First
Emma Johns, Gerry McKay, Miles Fisher
(more…)
April 2017 Br J Cardiol 2017;24:68-71 doi:10.5837/bjc.2017.010 Online First
Emma Johns, Gerry McKay, Miles Fisher
(more…)
January 2017 Br J Cardiol 2017;24:(1) doi:10.5837/bjc.2017.001 Online First
Emma Johns, Gerry McKay, Miles Fisher
(more…)
November 2007 Br J Cardiol 2007;14:267-71
James D Lee, Sakera Shaikh, John R Morrissey, Vinod Patel
The need for new guidelines The aim of the first guidelines from the Joint British Societies (JBS 1) was to promote a more effective multi-disciplinary approach to cardiovascular disease (CVD) prevention.4 The guidelines addressed the needs of both individuals with established disease and apparently healthy subjects at high risk of developing disease. The National Service Framework for Coronary Heart Disease (CHD) for England and Wales endorsed the lifestyle and risk factor targets in JBS 1.5 It also established national audit standards, which were subsequently reinforced and expanded by the General Medical Services contract for primary care.
September 2004 Br J Cardiol 2004;11:379-86
Norman K Hollenberg, Harold Schmitz, Ian MacDonald, Neil Poulter
No content available
You need to be a member to print this page.
Find out more about our membership benefits
You need to be a member to download PDF's.
Find out more about our membership benefits